IRIS
RINALDI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.113
AS - Asia 5.305
NA - Nord America 5.256
SA - Sud America 929
AF - Africa 64
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 23.675
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 8.638
US - Stati Uniti d'America 5.121
SG - Singapore 1.764
IE - Irlanda 1.108
CN - Cina 980
IT - Italia 907
VN - Vietnam 878
HK - Hong Kong 821
BR - Brasile 764
GB - Regno Unito 394
DE - Germania 320
KR - Corea 290
UA - Ucraina 173
IN - India 163
FR - Francia 118
JP - Giappone 109
GR - Grecia 82
FI - Finlandia 72
NL - Olanda 63
CA - Canada 62
TR - Turchia 55
AR - Argentina 53
MX - Messico 45
SE - Svezia 45
BD - Bangladesh 39
ID - Indonesia 29
EC - Ecuador 27
PL - Polonia 27
CO - Colombia 25
ES - Italia 25
RO - Romania 25
AT - Austria 23
PK - Pakistan 23
BE - Belgio 22
CZ - Repubblica Ceca 18
IQ - Iraq 18
ZA - Sudafrica 18
VE - Venezuela 16
EG - Egitto 15
IR - Iran 14
LT - Lituania 14
PE - Perù 11
AZ - Azerbaigian 10
CL - Cile 10
AE - Emirati Arabi Uniti 9
PH - Filippine 9
PY - Paraguay 9
SA - Arabia Saudita 9
TW - Taiwan 9
UZ - Uzbekistan 9
MA - Marocco 8
MY - Malesia 8
PT - Portogallo 8
CH - Svizzera 7
CR - Costa Rica 7
UY - Uruguay 7
BO - Bolivia 6
KZ - Kazakistan 6
NP - Nepal 6
OM - Oman 6
TN - Tunisia 6
AU - Australia 5
IL - Israele 5
JO - Giordania 5
KG - Kirghizistan 5
KE - Kenya 4
LB - Libano 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
BB - Barbados 3
CY - Cipro 3
DK - Danimarca 3
ET - Etiopia 3
EU - Europa 3
HN - Honduras 3
JM - Giamaica 3
MK - Macedonia 3
RS - Serbia 3
AM - Armenia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
MO - Macao, regione amministrativa speciale della Cina 2
PA - Panama 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
UG - Uganda 2
AL - Albania 1
AN - Antille olandesi 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
DM - Dominica 1
EE - Estonia 1
Totale 23.661
Salva come PNG Salva come JPEG
Città #
Moscow 3.025
Dublin 1.096
San Jose 839
Singapore 811
Hong Kong 802
Santa Clara 622
Chandler 399
Ashburn 301
Ho Chi Minh City 293
Jacksonville 292
Seoul 283
Hanoi 218
The Dalles 193
New York 180
Hefei 161
Naples 161
Princeton 153
Roxbury 148
Beijing 133
Dallas 106
Bremen 98
Bengaluru 93
Los Angeles 85
Caserta 83
Cambridge 82
São Paulo 75
Medford 73
Munich 63
Da Nang 61
Ann Arbor 58
Wilmington 49
Des Moines 48
Haiphong 42
Orem 42
Memphis 40
Amsterdam 37
Falkenstein 36
Chicago 35
Milan 34
Boardman 30
Napoli 29
Nanjing 28
Atlanta 27
Frankfurt am Main 27
Redwood City 25
Woodbridge 25
Helsinki 24
London 23
Brussels 21
Nuremberg 21
Chennai 20
Jinan 20
Washington 20
Mountain View 18
Warsaw 18
Hải Dương 17
Montreal 17
Belo Horizonte 16
Brooklyn 15
Houston 15
Rio de Janeiro 15
Tokyo 15
Aversa 14
Brasília 14
Hillsboro 14
Rome 14
Shenyang 14
Tianjin 14
Turku 14
Denver 13
Phoenix 13
Salvador 13
Toronto 13
Curitiba 12
Florence 12
Guayaquil 12
Lahore 12
Porto Alegre 12
Salerno 12
Buffalo 11
Giugliano In Campania 11
Manchester 11
Mexico City 11
Nha Trang 11
Norwalk 11
Shanghai 11
Stockholm 11
Thái Nguyên 11
Biên Hòa 10
Boston 10
Changsha 10
Hangzhou 10
Monserrato 10
Shenzhen 10
Vienna 10
Avellino 9
Dhaka 9
Istanbul 9
Mumbai 9
Taizhou 9
Totale 12.272
Salva come PNG Salva come JPEG
Nome #
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 221
Pulsed laser ablation of magnetic nanoparticles as a novel antibacterial strategy against gram positive bacteria 210
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 198
What changed in the Italian internal medicine and geriatric wards during the lockdown 197
A genic and epigenetic combination therapy for liver cancer 193
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 193
Bartter syndrome 191
Mechanisms and clinical behavior of hepatocellular carcinoma in HBV and HCV infection and alcoholic and non-alcoholic fatty liver disease 189
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 183
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 182
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 175
A Controversial Case of a Double Hepatic Incidentaloma in a Male Patient with Kidney Failure 168
Predictors of in-hospital mortality of COVID-19 patients and the role of telemetry in an internal medicine ward during the third phase of the pandemic 166
Chronic HCV infection and neurological and psychiatric disorders: an overview. 164
Renal phenotype in bardet-biedl syndrome: A combined defect of urinary concentration and dilution is associated with defective urinary aqp2 and umod excretion 163
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 163
Genetic characterization of Italian patients with Bardet-Biedl syndrome and correlation to ocular, renal and audio-vestibular phenotype: Identification of eleven novel pathogenic sequence variants 162
IMPACT OF TYPE II DIABETES ON HCC APPEARANCE IN PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 162
COVID-19 and arrhythmia: The factors associated and the role of myocardial electrical impulse propagation. An observational study based on cardiac telemetric monitoring 161
Features of microvessel density (MVD) and angiogenesis inhibitors in therapeutic approach of hepatocellular carcinoma (HCC) 161
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 159
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 158
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 158
Sonoporation by microbubbles as gene therapy approach against liver cancer 158
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 158
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment. 157
Predictors of early and late hepatocellular carcinoma recurrence 155
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience. 155
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 155
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 154
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 154
Atherosclerosis and chronic hepatitis C virus (HCV) infection: Role of liver steatosis 152
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 152
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 151
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 151
Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: a multicenter prospective study 151
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 151
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 150
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 149
Remdesivir plus dexamethasone versus dexamethasone alone for the treatment of COVID-19 patients requiring supplemental O2 therapy: a prospective controlled non-randomized study 149
Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management 148
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 147
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects? 146
[Next Generation Sequencing and ADPKD] 145
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 144
Diagnostic performance of LI-RADS in adult patients with rare hepatic tumors 144
Spirometry in elderly laryngectomized patients: A feasibility study 142
Chronic Hepatitis C Virus Infection and Depression. 141
[Inhibitors of intra-cystic secretion: novel therapies in ADPKD (Autosomal Dominant Polycystic Kidney Disease)] 141
Clinical application of lung ultrasound score on COVID-19 setting: a regional experience in Southern Italy 141
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 141
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 140
Editorial – Role of Highly Active Antiretroviral Therapy (HAART) for the COVID-19 treatment 140
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era? 139
Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome 139
Efficacy of Unsupervised Self-Collected Mid-Turbinate FLOQSwabs for the Diagnosis of Coronavirus Disease 2019 (COVID-19) 138
Hepatic steatosis and necro-inflammatory activity overestimated liver stiffness by transient elastography in staging liver fibrosis in chronic hepatitis C 135
HCC and molecular targeting therapies: Back to the future 135
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 134
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 134
Cardiovascular benefits from gliflozins: Effects on endothelial function 134
Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals 133
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 132
Liver Involvement in Patients With Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis 131
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 131
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 130
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 130
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 130
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 130
La epatite cronica da HCV con steatosi si associa ad elevato rischio aterosclerotico. 128
Oncolytic viruses in combination therapeutic approaches with epigenetic modulators: Past, present, and future perspectives 127
Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 127
Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights 126
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 126
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients 126
Liver Involvement during SARS-CoV-2 Infection Is Associated with a Worse Respiratory Outcome in COVID-19 Patients 125
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 125
HCV-related steatosis and risk of atherosclerosis 125
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 124
Antibiotic use and associated factors in a large sample of hospitalised older people 124
Association between the spread of COVID-19 and weather-climatic parameters 124
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 124
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 123
Circulating Vitamin D Level and Its Impact on Mortality and Recurrence in Stage III Colorectal Cancer Patients: A Systematic Review and Meta-Analysis 122
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. 122
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study 119
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence 118
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 118
Patho-physiology of renal dysfunction in Bardet-Biedl Syndrome 118
Ruolo patogenetico dell’adiponectina nella steatosi associata ad epatite C 117
NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations. 117
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 117
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 116
Renal handling of uric acid 116
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 116
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 115
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. 115
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 114
Different serological, molecular and cytokine profiles characterize active and inactive disease in patients with chronic hepatitis B virus (HBV) infection 114
Physician Attitudes and Perceptions of Complementary and Alternative Medicine (CAM): A Multicentre Italian Study 114
Totale 14.416
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.024
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.024
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202125 0 0 0 0 0 0 0 0 0 0 0 25
2021/2022964 25 4 16 27 297 20 15 23 71 64 84 318
2022/20231.940 179 61 55 86 238 121 6 98 993 21 35 47
2023/20241.111 84 30 55 64 306 169 36 38 21 40 92 176
2024/20253.362 29 65 18 59 524 396 479 308 513 399 319 253
2025/202614.988 622 713 710 668 1.287 7.981 955 594 717 321 280 140
Totale 24.138